One in six South Africans drug resistant before starting HIV treatment
How many people who have used PrEP get HIV the same year? New York study finds out
South Africa reports successful third-line HIV treatment programme
How dangerous is gonorrhoea resistance and can it be halted?
Fostemsavir, novel gp120 inhibitor, salvages nearly half of people with no other treatment options left
Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows
